Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 14 March 2022

Yesterday’s UK 100 Leaders Price (p) % Chg
PEARSON PLC 766.6 18.0%
POLYMETAL INTERNATIONAL PLC 169.5 12.1%
MELROSE INDUSTRIES PLC 122.0 7.3%
FLUTTER ENTERTAINMENT PLC-DI 8,950.0 4.8%
ENTAIN PLC 1,528.0 4.3%
Yesterday’s UK 100 Laggards Price (p) % Chg
FRESNILLO PLC 730.2 -4.7%
UNITED UTILITIES GROUP PLC 1052.5 -1.9%
SEVERN TRENT PLC 2825.0 -1.9%
NATIONAL GRID PLC 1113.4 -1.8%
SSE PLC 1648.0 -1.4%

 

Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,156 0.8% 5.8%
DOW JONES INDUS. AVG 32,944 -0.7% 0.5%
DAX INDEX 13,628 1.4% -6.0%
NIKKEI 225 25,308 0.6% -14.8%
S&P/ASX 200 INDEX 7,149 1.2% 5.7%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 105.65 -3.37%
Brent Crude (ICE) USD/bbl. 109.28 -3.01%
Gold Spot USD/t oz. 1,974 -0.7%
Copper (Comex) USd/lb. 457 -1.2%
The UK 100 is called to open +45 points today at 7200. 

1 day; 2 Years

Click graph to enlarge

Markets Overview:

 

The UK 100 is called to open +45 points today at 7200.   The UK 100 is expected to open modestly higher amid hopes the Russia-Ukraine conflict could be headed towards a ceasefire and possible end. After, Ukraine’s president, Volodymyr Zelensky, indicated he would meet Vladimir Putin for peace talks.  Asia’s main stock markets were mixed with Japan and Australia higher, and China and Korea headed lower.

 

Company News & Broker Comments:

 

Company News:

Aston Martin confirms Doug Lafferty to join as CFO on May 1st.
AstraZeneca state that the US FDA has approved its cancer drug Lynparza, jointly developed with Merk & Co as a treatment for patients with early-stage breast cancer with certain mutations.
Bodycote reports a FY21 pretax profit of £77.5m (2020: £1.5m loss) as they plan to pay dividend "that is sustainable and grows over time".
 
British American Tobacco will exit Russia and cut its fiscal 2022 guidance as a result.
 
ConvaTec says acquisition of Triad Life Sciences now complete.
 
London Stock Exchange will suspend all products and services for Russia.
Rio Tinto are to acquire a 49% of Turquoise Hill for CAD34 per share cash, at a value of around $2.7bn.

Broker Comments

 

No new broker comments

 

Reporting Today:

 

Bodycote

 

Phoenix Group Holdings

 

Reporting Tomorrow:

 

Close Brothers

 

Ferguson

 

Genuit Group

 

Informa

 

TI Fluid systems

 

TP ICAP

 

Ultra Electronics Holdings

 

In Focus Today:

 

Chinese FDI - Foreign Direct Investment

 

This Week's Ex-Dividends:

 

FTSE 100:

M&G

 

NatWest Group

 

Anglo American

 

Hikma Pharmaceuticals

 

SEGRO

 

FTSE 250:

BlackRock World Mining Trust

 

Crest Nicholson Holdings

 

BB Healthcare Trust

 

Spirent Communications

 

Dunelm Group

 

HgCapital Trust

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.